Rapid plasma clearance of albumin-acrolein adduct in rats

Kashyap N. Thakore, Jose C. Gan, Ghulam Ansari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Protein adducts are used as markers of chemical exposure. Determination of the clearance rate of these adducts from the blood circulation will provide the time frame for their measurement. Radioactive albumin was prepared biosynthetically by repeated intraperitoneal injections of l-[4,5-3H]lysine to a rat. After an affinity purification, an aliquot of this native [3H-lysine]albumin was adducted with 5 mM acrolein. Both the native albumin (A-treated group) and the albumin-acrolein adduct (AAA-treated group) were intravenously injected to separate groups of rats, and the clearance of radioactivity from the plasma was measured as a function of time. At the end of the experiment (33 h after the injection), radioactivity in the whole plasma, and in homogenates of liver, kidney and spleen and their trichloroacetic acid(TCA)-soluble and -insoluble fractions in both A- and AAA-treated groups, was measured. The results, at the initial 11 h after the injection, showed that the radioactivity was cleared from the circulating plasma more rapidly in the AAA-treated group (32% of the injected radioactivity remained) than the A-treated group (52%). At 33 h after the injection, 22% of the injected radioactivity remained in the plasma in the AAA-treated group as compared to 32% in the A-treated group. The whole homogenates of liver and kidney and their corresponding TCA-soluble fractions showed higher radioactivity in the AAA-treated group as compared to the A-treated group. However, the TCA-insoluble fractions from livers and kidneys of the AAA-treated group showed lower radioactivity as compared to the A-treated group. These results indicated that the albumin-acrolein adduct was removed more rapidly from the circulation than the native albumin, and degraded more rapidly by the liver and kidney. There was no preferential removal or degradation of the adducted albumin by the spleen.

Original languageEnglish (US)
Pages (from-to)27-37
Number of pages11
JournalToxicology Letters
Volume71
Issue number1
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Acrolein
Radioactivity
Serum Albumin
Rats
Albumins
Plasmas
Liver
Trichloroacetic Acid
Kidney
Injections
Lysine
Spleen
Blood Circulation
Hemodynamics
Intraperitoneal Injections
Purification
Degradation

Keywords

  • Acrolein
  • Albumin adduct
  • Plasma clearance
  • Protein degradation

ASJC Scopus subject areas

  • Toxicology

Cite this

Rapid plasma clearance of albumin-acrolein adduct in rats. / Thakore, Kashyap N.; Gan, Jose C.; Ansari, Ghulam.

In: Toxicology Letters, Vol. 71, No. 1, 1994, p. 27-37.

Research output: Contribution to journalArticle

Thakore, Kashyap N. ; Gan, Jose C. ; Ansari, Ghulam. / Rapid plasma clearance of albumin-acrolein adduct in rats. In: Toxicology Letters. 1994 ; Vol. 71, No. 1. pp. 27-37.
@article{e6f7704c69534188aa65d0084e26f09e,
title = "Rapid plasma clearance of albumin-acrolein adduct in rats",
abstract = "Protein adducts are used as markers of chemical exposure. Determination of the clearance rate of these adducts from the blood circulation will provide the time frame for their measurement. Radioactive albumin was prepared biosynthetically by repeated intraperitoneal injections of l-[4,5-3H]lysine to a rat. After an affinity purification, an aliquot of this native [3H-lysine]albumin was adducted with 5 mM acrolein. Both the native albumin (A-treated group) and the albumin-acrolein adduct (AAA-treated group) were intravenously injected to separate groups of rats, and the clearance of radioactivity from the plasma was measured as a function of time. At the end of the experiment (33 h after the injection), radioactivity in the whole plasma, and in homogenates of liver, kidney and spleen and their trichloroacetic acid(TCA)-soluble and -insoluble fractions in both A- and AAA-treated groups, was measured. The results, at the initial 11 h after the injection, showed that the radioactivity was cleared from the circulating plasma more rapidly in the AAA-treated group (32{\%} of the injected radioactivity remained) than the A-treated group (52{\%}). At 33 h after the injection, 22{\%} of the injected radioactivity remained in the plasma in the AAA-treated group as compared to 32{\%} in the A-treated group. The whole homogenates of liver and kidney and their corresponding TCA-soluble fractions showed higher radioactivity in the AAA-treated group as compared to the A-treated group. However, the TCA-insoluble fractions from livers and kidneys of the AAA-treated group showed lower radioactivity as compared to the A-treated group. These results indicated that the albumin-acrolein adduct was removed more rapidly from the circulation than the native albumin, and degraded more rapidly by the liver and kidney. There was no preferential removal or degradation of the adducted albumin by the spleen.",
keywords = "Acrolein, Albumin adduct, Plasma clearance, Protein degradation",
author = "Thakore, {Kashyap N.} and Gan, {Jose C.} and Ghulam Ansari",
year = "1994",
doi = "10.1016/0378-4274(94)90195-3",
language = "English (US)",
volume = "71",
pages = "27--37",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Rapid plasma clearance of albumin-acrolein adduct in rats

AU - Thakore, Kashyap N.

AU - Gan, Jose C.

AU - Ansari, Ghulam

PY - 1994

Y1 - 1994

N2 - Protein adducts are used as markers of chemical exposure. Determination of the clearance rate of these adducts from the blood circulation will provide the time frame for their measurement. Radioactive albumin was prepared biosynthetically by repeated intraperitoneal injections of l-[4,5-3H]lysine to a rat. After an affinity purification, an aliquot of this native [3H-lysine]albumin was adducted with 5 mM acrolein. Both the native albumin (A-treated group) and the albumin-acrolein adduct (AAA-treated group) were intravenously injected to separate groups of rats, and the clearance of radioactivity from the plasma was measured as a function of time. At the end of the experiment (33 h after the injection), radioactivity in the whole plasma, and in homogenates of liver, kidney and spleen and their trichloroacetic acid(TCA)-soluble and -insoluble fractions in both A- and AAA-treated groups, was measured. The results, at the initial 11 h after the injection, showed that the radioactivity was cleared from the circulating plasma more rapidly in the AAA-treated group (32% of the injected radioactivity remained) than the A-treated group (52%). At 33 h after the injection, 22% of the injected radioactivity remained in the plasma in the AAA-treated group as compared to 32% in the A-treated group. The whole homogenates of liver and kidney and their corresponding TCA-soluble fractions showed higher radioactivity in the AAA-treated group as compared to the A-treated group. However, the TCA-insoluble fractions from livers and kidneys of the AAA-treated group showed lower radioactivity as compared to the A-treated group. These results indicated that the albumin-acrolein adduct was removed more rapidly from the circulation than the native albumin, and degraded more rapidly by the liver and kidney. There was no preferential removal or degradation of the adducted albumin by the spleen.

AB - Protein adducts are used as markers of chemical exposure. Determination of the clearance rate of these adducts from the blood circulation will provide the time frame for their measurement. Radioactive albumin was prepared biosynthetically by repeated intraperitoneal injections of l-[4,5-3H]lysine to a rat. After an affinity purification, an aliquot of this native [3H-lysine]albumin was adducted with 5 mM acrolein. Both the native albumin (A-treated group) and the albumin-acrolein adduct (AAA-treated group) were intravenously injected to separate groups of rats, and the clearance of radioactivity from the plasma was measured as a function of time. At the end of the experiment (33 h after the injection), radioactivity in the whole plasma, and in homogenates of liver, kidney and spleen and their trichloroacetic acid(TCA)-soluble and -insoluble fractions in both A- and AAA-treated groups, was measured. The results, at the initial 11 h after the injection, showed that the radioactivity was cleared from the circulating plasma more rapidly in the AAA-treated group (32% of the injected radioactivity remained) than the A-treated group (52%). At 33 h after the injection, 22% of the injected radioactivity remained in the plasma in the AAA-treated group as compared to 32% in the A-treated group. The whole homogenates of liver and kidney and their corresponding TCA-soluble fractions showed higher radioactivity in the AAA-treated group as compared to the A-treated group. However, the TCA-insoluble fractions from livers and kidneys of the AAA-treated group showed lower radioactivity as compared to the A-treated group. These results indicated that the albumin-acrolein adduct was removed more rapidly from the circulation than the native albumin, and degraded more rapidly by the liver and kidney. There was no preferential removal or degradation of the adducted albumin by the spleen.

KW - Acrolein

KW - Albumin adduct

KW - Plasma clearance

KW - Protein degradation

UR - http://www.scopus.com/inward/record.url?scp=0028231275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028231275&partnerID=8YFLogxK

U2 - 10.1016/0378-4274(94)90195-3

DO - 10.1016/0378-4274(94)90195-3

M3 - Article

C2 - 8140586

AN - SCOPUS:0028231275

VL - 71

SP - 27

EP - 37

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 1

ER -